Literature DB >> 33691728

Signaling pathways in intestinal homeostasis and colorectal cancer: KRAS at centre stage.

Camille Ternet1, Christina Kiel2.   

Abstract

The intestinal epithelium acts as a physical barrier that separates the intestinal microbiota from the host and is critical for preserving intestinal homeostasis. The barrier is formed by tightly linked intestinal epithelial cells (IECs) (i.e. enterocytes, goblet cells, neuroendocrine cells, tuft cells, Paneth cells, and M cells), which constantly self-renew and shed. IECs also communicate with microbiota, coordinate innate and adaptive effector cell functions. In this review, we summarize the signaling pathways contributing to intestinal cell fates and homeostasis functions. We focus especially on intestinal stem cell proliferation, cell junction formation, remodelling, hypoxia, the impact of intestinal microbiota, the immune system, inflammation, and metabolism. Recognizing the critical role of KRAS mutants in colorectal cancer, we highlight the connections of KRAS signaling pathways in coordinating these functions. Furthermore, we review the impact of KRAS colorectal cancer mutants on pathway rewiring associated with disruption and dysfunction of the normal intestinal homeostasis. Given that KRAS is still considered undruggable and the development of treatments that directly target KRAS are unlikely, we discuss the suitability of targeting pathways downstream of KRAS as well as alterations of cell extrinsic/microenvironmental factors as possible targets for modulating signaling pathways in colorectal cancer. Video Abstract.

Entities:  

Keywords:  Colorectal cancer; Hypoxia; Inflammation; Intestinal stem cells; KRAS; MAPK pathway; Metabolic reprogramming; Microenvironment; Reactive oxygen species; Small GTPases

Mesh:

Substances:

Year:  2021        PMID: 33691728      PMCID: PMC7945333          DOI: 10.1186/s12964-021-00712-3

Source DB:  PubMed          Journal:  Cell Commun Signal        ISSN: 1478-811X            Impact factor:   5.712


  220 in total

Review 1.  Hypoxia in cancer: significance and impact on clinical outcome.

Authors:  Peter Vaupel; Arnulf Mayer
Journal:  Cancer Metastasis Rev       Date:  2007-06       Impact factor: 9.264

2.  Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer.

Authors:  Hirotoshi Kikuchi; Maria S Pino; Min Zeng; Senji Shirasawa; Daniel C Chung
Journal:  Cancer Res       Date:  2009-10-20       Impact factor: 12.701

Review 3.  Regulation of small GTPases at epithelial cell-cell junctions.

Authors:  Sandra Citi; Domenica Spadaro; Yann Schneider; Jeffrey Stutz; Pamela Pulimeno
Journal:  Mol Membr Biol       Date:  2011-07-25       Impact factor: 2.857

Review 4.  Regulation and plasticity of intestinal stem cells during homeostasis and regeneration.

Authors:  Joep Beumer; Hans Clevers
Journal:  Development       Date:  2016-10-15       Impact factor: 6.868

Review 5.  Intestinal epithelial cells: regulators of barrier function and immune homeostasis.

Authors:  Lance W Peterson; David Artis
Journal:  Nat Rev Immunol       Date:  2014-03       Impact factor: 53.106

Review 6.  Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Trends Pharmacol Sci       Date:  2012-03-06       Impact factor: 14.819

7.  Intestinal tolerance requires gut homing and expansion of FoxP3+ regulatory T cells in the lamina propria.

Authors:  Usriansyah Hadis; Benjamin Wahl; Olga Schulz; Matthias Hardtke-Wolenski; Angela Schippers; Norbert Wagner; Werner Müller; Tim Sparwasser; Reinhold Förster; Oliver Pabst
Journal:  Immunity       Date:  2011-02-17       Impact factor: 31.745

8.  Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.

Authors:  Byoung-San Moon; Woo-Jeong Jeong; Jieun Park; Tae Il Kim; Do Sik Min; Kang-Yell Choi
Journal:  J Natl Cancer Inst       Date:  2014-02       Impact factor: 13.506

Review 9.  Targeting HIF-1 for cancer therapy.

Authors:  Gregg L Semenza
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

10.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

View more
  1 in total

1.  Gut microbiota composition in chemotherapy and targeted therapy of patients with metastatic colorectal cancer.

Authors:  Yen-Cheng Chen; Chia-Hsien Chuang; Zhi-Feng Miao; Kwan-Ling Yip; Chung-Jung Liu; Ling-Hui Li; Deng-Chyang Wu; Tian Lu Cheng; Chung-Yen Lin; Jaw-Yuan Wang
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.